Aileron Therapeutics Stock Price - ALRN

-0.01 (-1.41%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aileron Therapeutics Inc ALRN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.01 -1.41% 0.70 0.67 0.728 0.67 0.71 10:10:36
Bid Price Ask Price Spread Spread % News
0.6802 0.73 0.0498 6.82% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
422 156,352 $ 0.7057446 $ 110,345 302,511 0.40 - 2.60
Last Trade Time Type Quantity Stock Price Currency
10:10:36 200 $ 0.70 USD

Aileron Therapeutics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 19.75M 27.81M $ -31.55M -2.14 - 26.80M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 3.00 3.60%

more financials information »

Aileron Therapeutics News

Loading Messages....

Latest ALRN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ALRN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.710.7280.550.6916006232,659-0.01-1.41%
1 Month0.79930.830.550.7321113213,746-0.0993-12.42%
3 Months0.50020.870.4350.6619752281,0430.199839.94%
6 Months0.601.050.400.6142764401,4340.1016.67%
1 Year1.932.600.400.8064578317,467-1.23-63.73%
3 Years13.7515.480.402.07175,065-13.05-94.91%
5 Years13.7515.480.402.07175,065-13.05-94.91%

Aileron Therapeutics Description

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing and commercializing a novel class of therapeutics called stapled peptides. Its lead product candidate, ALRN-6924, targets the tumor suppressor p53 for the treatment of a wide variety of cancers. It reactivates p53-mediated tumor suppression by targeting the two primary p53 suppressor proteins, MDMX and MDM2.

Your Recent History
Aileron Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.